Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
D. Fedson, J. Henrichsen, P.H. Makela, R. Austrian.
WHO recommendations on pneumococcal vaccination: immunization of elderly people with polyvalent pneumococcal vaccine.
Infection, 17 (1989), pp. 431-441
[2.]
Subdirección General de Prestaciones y Evaluación de Tecnologías Sanitarias..
Informe sobre vacuna neumocócica.
Med Clin (Barc), 102 (1994), pp. 383-386
[3.]
CDC. Prevention of pneumococcal disease:.
recommendations of the Advisory Committee on Immunization Practices.
MMWR, 46 (1997), pp. 1-24
[4.]
CDC.
Influenza and pneumococcal vaccination levels among adults ≥ 65 years-United States, 1997.
JAMA, 280 (1998), pp. 1818-1819
[5.]
R.V. Sims, W.C. Steinmann, J.H. McConville, L.R. King, W.C. Zwick, J.S. Schwartz.
The clinical effectiveness of pneumococcal vaccine in the elderly.
Ann Intern Med, 108 (1988), pp. 653-657
[6.]
E.D. Shapiro, A.T. Berg, R. Austrian, D. Schroeder, V. Parcells, A. Murgolis, et al.
The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.
N Engl J Med, 325 (1991), pp. 1453-1460
[7.]
J.C. Butler, R.F. Breiman, J.F. Campbell, H.B. Lipman, C.V. Broome, R.R. Facklam.
Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations.
JAMA, 270 (1993), pp. 1826-1831
[8.]
I. Koivula, M. Sten, M. Leinonen, P.H. Makela.
Clinical efficacy of pneumococcal vaccine in the elderly: a randomised, single-blind population-based trial.
Am J Med, 103 (1997), pp. 281-290
[9.]
J.E. Sisk, A.J. Moskowitz, W. Whang, J.D. Lin, D.S. Fedson, A.M. McBean, et al.
Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.
JAMA, 278 (1997), pp. 1333-1339
Copyright © 2001. Sociedad Española de Geriatría y Gerontología
